Highlights Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Market Closed - Nasdaq Copenhagen Other stock markets 10:30:07 2024-04-26 am EDT			5-day change	1st Jan Change
0.251 ^DKK	-1.95%		-16.05%	-41.63%

Apr. 10	Pharma Equity Group A/S announced that it has received DKK 7.6 million in funding	CI
Apr. 05	Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharma Equity Group?s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company?s patented drug candidate RNX-051	Apr. 05	CI
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Pharma Equity Group A/S Provides Group Earnings Guidance for the Full Year 2024	Mar. 20	CI
Pharma Equity Group's Subsidiary (Reponex Pharmaceuticals A/S) Receives Notification from the European Patent Office	Jan. 22	CI
Pharma Equity Group A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Jan. 17	CI
Pharma Equity Group A/S Announces Positive Preliminary Results from the Phase-2 Clinical Trial	Nov. 16	CI
Pharma Equity Group?S Subsidiary Company Reponex Pharmaceuticals A/S Receives Grant of Us Patent for A Method of Treatment on Its Topical Wound-Healing Composition	23-10-31	CI
Pharma Equity Group A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
Reponex Pharmaceuticals Set for US Patent for Chronic Wound Treatment Method	23-08-15	MT
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Pharma Equity Group A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Pharma Equity Group A/S Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Reponex Pharmaceuticals A/S completed the acquisition of Pharma Equity Group A/S.	23-03-23	CI
Bonus Issue: 1 new share for 1 existing share	23-01-26	FA
Blue Vision A/S Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
Blue Vision A/S (CPSE:BLVIS A) made an offer to acquire Reponex Pharmaceuticals A/S.	22-04-04	CI
Blue Vision A/S Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Reverse Split: 1505 of 10000	19-10-31	FA
An outlandish company cancelled the acquisition of 79.3% stake in Portinho S.A. from Blue Vision A/S.	18-03-08	CI
H.C. Holding Investeringsaktieselskab A/S sold 9.01% stake in Blue Vision A/S.	17-06-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharma Equity Group A/S

Equities

PEG A

DK0061155009

Highlights

Filters